Pharmacokinetics of mycophenolate mofetil alone and in combination with valganciclovir in renal and heart transplant recipients

Trial Profile

Pharmacokinetics of mycophenolate mofetil alone and in combination with valganciclovir in renal and heart transplant recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2016

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Valganciclovir (Primary)
  • Indications Cytomegalovirus infections; Heart transplant rejection; Renal transplant rejection
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 May 2016 Status changed from recruiting to completed.
    • 02 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top